Health
Metformin treatment linked to slowed cognitive decline – WebWire
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels. A new research study, conducted over six year…
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels.
A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 diabetes who used metformin experienced slower cognitive decline with lower dementi…
-
Business16 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Business8 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?
-
General15 hours agoPope Leo condemns wealthy living in a bubble of luxury
-
Noosa News14 hours agoQueensland government to set up $400m energy investment fund